百蕊草对阿霉素肾病大鼠治疗作用的实验研究

宣伟东; 唐大海; 卞俊; 胡水根; 胡建峰; 范正平

doi:10.3969/j.issn.1006-0111.2012.06.013

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

百蕊草对阿霉素肾病大鼠治疗作用的实验研究

宣伟东, 唐大海, 卞俊, 胡水根, 胡建峰, 范正平

文章导航 > 药学实践与服务 > 2012 > 30(6): 443-446

宣伟东, 唐大海, 卞俊, 胡水根, 胡建峰, 范正平. 百蕊草对阿霉素肾病大鼠治疗作用的实验研究[J]. 药学实践与服务, 2012, 30(6): 443-446. doi: 10.3969/j.issn.1006-0111.2012.06.013

引用本文:

XUAN Wei-dong, TANG Da-hai, BIAN Jun, HU Shui-gen, HU Jiang-feng, FAN Zheng-ping. Therapeutic effects of Thesium chinensis on adriamycin-induced nephropathy rats[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 443-446. doi: 10.3969/j.issn.1006-0111.2012.06.013

Citation:

XUAN Wei-dong, TANG Da-hai, BIAN Jun, HU Shui-gen, HU Jiang-feng, FAN Zheng-ping. Therapeutic effects of Thesium chinensis on adriamycin-induced nephropathy rats[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 443-446. doi: 10.3969/j.issn.1006-0111.2012.06.013

百蕊草对阿霉素肾病大鼠治疗作用的实验研究

doi: 10.3969/j.issn.1006-0111.2012.06.013

解放军第411医院药学科, 上海 200081

基金项目: 上海市卫生局局级科研课题(2012085号).

Therapeutic effects of Thesium chinensis on adriamycin-induced nephropathy rats

Department of Pharmacy, the 411st Hospital of PLA, Shanghai 200081, China

摘要: 目的观察百蕊草对大鼠肾病综合征的治疗作用。方法 SD大鼠40只,10只为空白对照组,余下分为模型组,低剂量组(1.0 g/(kg·d)),高剂量组(5.0 g/(kg·d)),每组10只,尾静脉注射阿霉素6.0 mg/kg 建立肾病模型。连续灌胃给药5周,观察百蕊草对肾病大鼠尿量、24 h尿蛋白、血液生化指标、肾组织病理学等方面的影响。结果百蕊草能够减轻ADR大鼠肾病综合症烂尾、水肿等症状。与模型组相比,百蕊草治疗第2周以后,尿量显著增加(P<0.01),治疗3周后,24 h尿蛋白浓度下降(P<0.05),低剂量组尿蛋白浓度显著下降(P<0.01)。治疗5周后,低剂量组的血清总蛋白(TP)、血清蛋白(ALB)水平显著高于模型组(P<0.01),总胆固醇(TCH)、甘油三酯(TG)水平则显著降低(P<0.01)。结论百瑞草具有利尿、消除水肿、降低尿蛋白、降血脂、提高血清蛋白等作用,改善病理组织学变化,减轻肾脏损害,对肾病综合征大鼠具有良好的治疗效果。
- 百蕊草 /
- 药效学 /
- 阿霉素肾病 /
- SD大鼠 /
- 中药治疗
Abstract: Objective To investigate the therapeutic effects of Thesium chinensis Turcz on Adriamycin-induced nephropathy rats. Methods 40 SD rats were divided into 4 groups averagely:normal control group, model control group, low-dosage group (1.0 g/(kg·d) and high-dosage group(5.0 g/(kg·d). Nephritic syndrome models were established in 30 rats by intravenous injection of Adriamycin (6.0 mg/kg). The rats of low-dosage group and high-dosage group were intragastric administrated decoction of Thesium chinensis Turcz daily, the model control group rats were given running water(2 ml). During 5 weeks treatment process, the 24 hour urine volume, 24 hour urine protein concentration of rats were observed. The level of total serum protein(TP), serum albumin(ALP), total cholesterol(TCH), triglycerides(TG) and UREA were determined, and the pathological changes of kidney tissue were assayed after the therapy process. Results The symptoms of nephritic syndromes, such as edema, tail-rot disease, were relieved by Thesium chinensis Turcz. After 2 weeks therapy, the 24 hour urine volume of low-dosage group and high-dosage group were significantly higher than model control, and the 24 hour urine protein concentration were significantly lower than model control after 3 weeks. The level of TP and ALP of low-dosage group were significantly higher than model control, as well as the level of TCH and TG were significantly lower after 5 weeks. Conclusion Thesium chinensis Turcz could eliminate tissue edema and decrease the urine protein concentration by diuretic action and improves renal pathology to protect the kidney from damage by reducing the serum cholesterol level, decreased blood lipid content, and increased the plasma protein level.
- Thesium chinensis Turcz /
- pharmacology /
- Adriamycin-induced nephritic syndrome /
- SD rats /
- TCD therapy

[1]	国家中医药管理局,中华本草编委会.中华本草[M].上海:上海科技出版社,1999, 2:595.
[2]	Bertani T, Poggi A, Pozzoni R, et al. Adriamycin-induced nephritic syndrome in rats[J]. Lab Invest, 1982, 46(1):16.
[3]	李保春,崔若兰,张晓英.大鼠阿霉素肾病模型的建立[J].第二军医大学学报,1992, 13(5):485.
[4]	王峥,刘近明,李绍顺.百蕊草的研究进展[J].中国药师,2006, 9(11):1059.

[1]	唐淑慧, 凤美娟, 薛智霞, 鲁桂华. 帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
[2]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[3]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[4]	张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英. 二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
[5]	石晓萍, 吕迁洲, 李晓宇, 许青. 泊沙康唑对比伏立康唑经验治疗或诊断驱动治疗免疫功能低下患者侵袭性霉菌病的成本-效果分析 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202401050
[6]	崔亚玲, 吴琼, 马良煜, 胡北, 姚东, 许子华. 肝素钠肌醇烟酸酯乳膏中肌醇烟酸酯皮肤药动学研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404006
[7]	徐璐璐, 刘爱军. 丹参白术方“异病同治”冠心病、血管性痴呆、特发性膜性肾病的网络药理学作用机制研究 . 药学实践与服务, 2024, 42(12): 1-8. doi: 10.12206/j.issn.2097-2024.202312027
[8]	马兹芬, 许维恒, 金煜翔, 薛磊. 食管癌的靶向治疗与免疫治疗研究进展 . 药学实践与服务, 2024, 42(6): 231-237. doi: 10.12206/j.issn.2097-2024.202306008
[9]	丁千雪, 尚圣兰, 余梦辰, 余爱荣. 机器学习在肾病综合征患者他克莫司个体化用药中的应用 . 药学实践与服务, 2024, 42(6): 227-230, 243. doi: 10.12206/j.issn.2097-2024.202310007
[10]	宋泽成, 陈林林, 鲁仁义, 刘梦肖, 王彦. 脓毒症治疗的研究进展 . 药学实践与服务, 2024, 42(11): 457-460, 502. doi: 10.12206/j.issn.2097-2024.202405059
[11]	岳春华, 贲永光, 王海桥. 基于NLRP1炎症小体探讨百合知母汤抗抑郁的作用机制 . 药学实践与服务, 2024, 42(8): 325-333. doi: 10.12206/j.issn.2097-2024.202401033
[12]	徐飞, 陈瑾, 鲁育含, 李志勇. 肠道菌群参与糖尿病肾病的机制研究进展 . 药学实践与服务, 2024, 42(5): 181-184, 197. doi: 10.12206/j.issn.2097-2024.202312023
[13]	张成中, 朱雪艳, 卜其涛, 王宏瑞, 黄宝康. 基于网络药理学与分子对接预测鸡骨草特征图谱研究 . 药学实践与服务, 2024, 42(8): 350-358. doi: 10.12206/j.issn.2097-2024.202303048
[14]	夏哲炜, 曾垣烨, 朱海菲, 李育, 陈啸飞. 核磁共振磷谱法测定磷酸氢钙咀嚼片中药物含量 . 药学实践与服务, 2024, 42(9): 399-401, 406. doi: 10.12206/j.issn.2097-2024.202404063
[15]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[16]	赖立勇, 夏天爽, 徐圣焱, 蒋益萍, 岳小强, 辛海量. 中药青蒿抗氧化活性的谱效关系研究 . 药学实践与服务, 2024, 42(5): 203-210, 216. doi: 10.12206/j.issn.2097-2024.202211012
[17]	景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞. 黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
[18]	陈莹, 许子华, 胡北, 崔亚玲, 高欢, 吴琼. 通便灵胶囊治疗便秘的药效与机制研究 . 药学实践与服务, 2024, 42(): 1-7. doi: 10.12206/j.issn.2097-2024.202404008
[19]	杨嘉宁, 赵一颖, 肖伟. 七味脂肝方对非酒精性脂肪性肝炎动物模型的药效学评价 . 药学实践与服务, 2024, 42(9): 389-398. doi: 10.12206/j.issn.2097-2024.202404096
[20]	何静, 安晔, 张朝绅. 复方黑参滴丸与复方黑参丸药效学实验比较研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404009

点击查看大图

计量

文章访问数: 5074
HTML全文浏览量: 252
PDF下载量: 2077
被引次数: 0

百蕊草对阿霉素肾病大鼠治疗作用的实验研究

doi: 10.3969/j.issn.1006-0111.2012.06.013

解放军第411医院药学科, 上海 200081

基金项目: 上海市卫生局局级科研课题(2012085号).

收稿日期: 2012-04-28
修回日期: 2012-10-17

关键词:

百蕊草 /

药效学 /

阿霉素肾病 /

SD大鼠 /

中药治疗

摘要: 目的观察百蕊草对大鼠肾病综合征的治疗作用。方法 SD大鼠40只,10只为空白对照组,余下分为模型组,低剂量组(1.0 g/(kg·d)),高剂量组(5.0 g/(kg·d)),每组10只,尾静脉注射阿霉素6.0 mg/kg 建立肾病模型。连续灌胃给药5周,观察百蕊草对肾病大鼠尿量、24 h尿蛋白、血液生化指标、肾组织病理学等方面的影响。结果百蕊草能够减轻ADR大鼠肾病综合症烂尾、水肿等症状。与模型组相比,百蕊草治疗第2周以后,尿量显著增加(P<0.01),治疗3周后,24 h尿蛋白浓度下降(P<0.05),低剂量组尿蛋白浓度显著下降(P<0.01)。治疗5周后,低剂量组的血清总蛋白(TP)、血清蛋白(ALB)水平显著高于模型组(P<0.01),总胆固醇(TCH)、甘油三酯(TG)水平则显著降低(P<0.01)。结论百瑞草具有利尿、消除水肿、降低尿蛋白、降血脂、提高血清蛋白等作用,改善病理组织学变化,减轻肾脏损害,对肾病综合征大鼠具有良好的治疗效果。

English Abstract

Therapeutic effects of Thesium chinensis on adriamycin-induced nephropathy rats

Department of Pharmacy, the 411st Hospital of PLA, Shanghai 200081, China

Received Date: 2012-04-28
Rev Recd Date: 2012-10-17

Keywords:

Abstract: Objective To investigate the therapeutic effects of Thesium chinensis Turcz on Adriamycin-induced nephropathy rats. Methods 40 SD rats were divided into 4 groups averagely:normal control group, model control group, low-dosage group (1.0 g/(kg·d) and high-dosage group(5.0 g/(kg·d). Nephritic syndrome models were established in 30 rats by intravenous injection of Adriamycin (6.0 mg/kg). The rats of low-dosage group and high-dosage group were intragastric administrated decoction of Thesium chinensis Turcz daily, the model control group rats were given running water(2 ml). During 5 weeks treatment process, the 24 hour urine volume, 24 hour urine protein concentration of rats were observed. The level of total serum protein(TP), serum albumin(ALP), total cholesterol(TCH), triglycerides(TG) and UREA were determined, and the pathological changes of kidney tissue were assayed after the therapy process. Results The symptoms of nephritic syndromes, such as edema, tail-rot disease, were relieved by Thesium chinensis Turcz. After 2 weeks therapy, the 24 hour urine volume of low-dosage group and high-dosage group were significantly higher than model control, and the 24 hour urine protein concentration were significantly lower than model control after 3 weeks. The level of TP and ALP of low-dosage group were significantly higher than model control, as well as the level of TCH and TG were significantly lower after 5 weeks. Conclusion Thesium chinensis Turcz could eliminate tissue edema and decrease the urine protein concentration by diuretic action and improves renal pathology to protect the kidney from damage by reducing the serum cholesterol level, decreased blood lipid content, and increased the plasma protein level.